Synthesis, characterization and in vivo anticonvulsant and neurotoxicity screening of Schiff bases of phthalimide

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 3, 2011, Pages 375-380

  Bhat, Mashooq A ^a   Al Omar, Mohammed A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

MES test; Neurotoxicity; Phthalimide; Schiff base

Indexed keywords

4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' (3 NITROPHENYL)METHYLENEBENZOHYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' (3,4 DIMETHOXYPHENYL)METHYLENEBENZOHYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(4 HYDROXYPHENYL)METHYLENE]BENZOHYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)BENZOIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHYL 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)BENZOATE; PHENOBARBITAL; PHENYTOIN; PHTHALIMIDE DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC CURRENT; IN VIVO STUDY; MALE; MAXIMAL ELECTROSHOCK SEIZURE; MELTING POINT; MOUSE; NEUROTOXICITY; NONHUMAN; SEIZURE; SUBSTITUTION REACTION; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; MALE; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; PHTHALIMIDES; SCHIFF BASES; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 79956304504     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Shank R.P., Gordoeki J.F., Streter A.J.: Epilepsia 41, 53 (2000).
2. Kubota M., Nishi-Nagase M., Sakakihora Y.: Brain Dev. 22, 230 (2000).
3. French J.A.: Epilepsia 40, 1566 (1999).
4. Pandeya, S. N., Raja A.S., Stables J. P.: J. Pharm. Pharm. Sci. 5, 266 (2002).
5. Yogeeswari P., Sriram D., Sarawat V.J., Vaigunda R.M., Kumar M., Murugesan S., Thirumurugan R., Stables J. P.: Eur. J. Pharm. Sci. 20, 341 (2003).
6. Machado A.L., Lima L.M., Araujo J.X., Fraga C.A.M., Goncalves Koatz V.L., Berreiro E.J.: Bioorg. Med. Chem. Lett. 15, 1169 (2005).
7. Antunes R., Batista H., Srivastava R.M., Thomas G., Araujo C.C.: Bioorg. Med. Chem. Lett. 8, 3071 (1998).
8. Sena V.L.M., Srivastava R.M., Silva R.O., Lima V L.M.: Farmaco 58, 1283 (2003).
9. Siddiqui N., Pandeya S.N., Khan, S.A., Stables J., Rana A., Alam M., Arshad M.F., Bhat M.A.: Bioorg. Med. Chem. Lett. 17, 255 (2007).
10. Rana A., Siddiqui N., Khan S.A., Haque S.E., Bhat M.A.: Eur. J. Med. Chem. 43, 1114 (2008).
11. Bhat M.A., Siddiqui N., Khan, S.A., Mohamed M.I.: Acta Pol. Pharm. Drug Res. 66, 625 (2009).
12. Pandeya S.N., Kohli S., Siddiqui N., Stables J.P.: Pol. J. Pharmacol. 55, 565 (2003).
13. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., Swinyard E.A.: Epilepsia 19, 409 (1978).